The MATTERHORN Phase III trial has demonstrated that a perioperative regimen combining AstraZeneca’s Imfinzi (durvalumab) with FLOT chemotherap ...
A researcher at the Wintrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences received a ...
Presented positive updated data from ASPEN-06 Phase 2 trial demonstrating evorpacept generates strong response and durable ...
As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.
A study conducted by researchers at the University of Tartu showed a nearly five-fold enrichment of hereditary cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback